dapsone has been researched along with 2019 Novel Coronavirus Disease in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The data on the effect of treatments used for pemphigus on COVID-19 are limited." | 2.66 | Pemphigus and COVID-19: Critical overview of management with a focus on treatment choice. ( Atasoy, M; Demirbaş, A; Elmas, ÖF; Lotti, T; Türsen, Ü, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 8 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frade, MAC | 1 |
| Bernardes Filho, F | 1 |
| Lima, ALQ | 1 |
| Menezes, MB | 1 |
| Lugão, HB | 1 |
| Kanwar, B | 1 |
| Khattak, A | 1 |
| Kast, RE | 2 |
| Farouk, A | 1 |
| Salman, S | 1 |
| Altschuler, EL | 1 |
| Lee, JH | 1 |
| An, HK | 1 |
| Sohn, MG | 1 |
| Kivela, P | 1 |
| Oh, S | 1 |
| Elmas, ÖF | 1 |
| Demirbaş, A | 1 |
| Türsen, Ü | 1 |
| Atasoy, M | 1 |
| Lotti, T | 1 |
| Tripathi, T | 1 |
| Singh, AR | 1 |
| Kapoor, R | 1 |
| Sinha, A | 1 |
| Ghosh, S | 1 |
| Kaur, K | 1 |
| Pokhariya, D | 1 |
| Maity, S | 1 |
| Tapadar, A | 1 |
| Chandra, A | 1 |
| Cerqueira, SRPS | 1 |
| Deps, PD | 1 |
| Cunha, DV | 1 |
| Bezerra, NVF | 1 |
| Barroso, DH | 1 |
| Pinheiro, ABS | 1 |
| Pillegi, GS | 1 |
| Repsold, TAR | 1 |
| Kurizky, PS | 1 |
| Collin, SM | 1 |
| Gomes, CM | 1 |
1 review available for dapsone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Pemphigus and COVID-19: Critical overview of management with a focus on treatment choice.
Topics: COVID-19; Dapsone; Dermatologic Agents; Doxycycline; Glucocorticoids; Humans; Immunoglobulins, Intra | 2020 |
7 other studies available for dapsone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Asymptomatic low pulse oximetry measurements in leprosy patients in the time of COVID-19: Dapsone side effect.
Topics: COVID-19; Dapsone; Humans; Leprosy; Oximetry; SARS-CoV-2 | 2022 |
Dapsone Lowers Neutrophil to Lymphocyte Ratio and Mortality in COVID-19 Patients Admitted to the ICU.
Topics: COVID-19; Dapsone; Humans; Intensive Care Units; Lymphocytes; Neutrophils; Retrospective Studies | 2022 |
Dapsone and doxycycline could be potential treatment modalities for COVID-19.
Topics: Anti-Inflammatory Agents; Betacoronavirus; Chemotaxis, Leukocyte; Coronavirus Infections; COVID-19; | 2020 |
Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS).
Topics: Adult; Betacoronavirus; Chemotaxis, Leukocyte; Colchicine; Coronavirus Infections; COVID-19; Dapsone | 2020 |
4,4'-Diaminodiphenyl Sulfone (DDS) as an Inflammasome Competitor.
Topics: Alzheimer Disease; Clofazimine; Cognitive Dysfunction; Coronavirus Infections; COVID-19; Dapsone; Hu | 2020 |
Dapsone-induced methaemoglobinaemia in leprosy: a close mimic of 'happy hypoxia' in the COVID-19 pandemic.
Topics: COVID-19; Dapsone; Humans; Hypoxia; Leprosy; Methemoglobinemia; Pandemics; SARS-CoV-2 | 2021 |
The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19: A prospective real-world cohort study.
Topics: Adrenal Cortex Hormones; BCG Vaccine; Brazil; Clofazimine; Cohort Studies; COVID-19; COVID-19 Drug T | 2021 |